LENZ (LENZ Therapeutics) Change In Inventory: $-0.89 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LENZ LENZ Therapeutics Inc LENZ
12 GF Score
Price $5.29
! 2 Warning Signs
View Full Analysis

What is LENZ Therapeutics Change In Inventory?

LENZ Therapeutics LENZ -7.99% 12 Change In Inventory is $-0.89 Mil as of Mar. 2026. GuruFocus rates LENZ with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

LENZ Therapeutics's change in inventory for the quarter that ended in Mar. 2026 was $-0.89 Mil. It means LENZ Therapeutics's inventory increased by $0.89 Mil from Dec. 2025 to Mar. 2026 .

LENZ Therapeutics's change in inventory for the fiscal year that ended in Dec. 2025 was $-4.28 Mil. It means LENZ Therapeutics's inventory increased by $4.28 Mil from Dec. 2024 to Dec. 2025 .

LENZ Therapeutics's Total Inventories for the quarter that ended in Mar. 2026 was $3.50 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LENZ Therapeutics's Days Inventory for the quarter that ended in Mar. 2026 was 272.82.

Inventory Turnover measures how fast the company turns over its inventory within a year. LENZ Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LENZ Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.69.

LENZ Therapeutics  (NAS:LENZ) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LENZ Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=3.217/1.076*365 / 4
=272.82

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LENZ Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.076 / 3.217
=0.33

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LENZ Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=3.217 / 1.901
=1.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics Change In Inventory Related Terms

LENZ Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for LENZ Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics Change In Inventory Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
0.00 0.00 0.00 0.00 -4.28

LENZ Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.89
LENZ
12GF Score
LENZ Therapeutics Inc LENZ
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LENZ Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.89 Mil mean?
LENZ Therapeutics (LENZ) has a Change In Inventory of $-0.89 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for LENZ Therapeutics and its competitors.
Is LENZ Therapeutics' Change In Inventory too high?
LENZ Therapeutics' current Change In Inventory is $-0.89 Mil. Overall, LENZ Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LENZ Therapeutics' Change In Inventory compare to NGEN and ARMP?
LENZ Therapeutics' Change In Inventory of $-0.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for LENZ Therapeutics and its competitors. LENZ Therapeutics's current Change In Inventory is $-0.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENZ Therapeutics stock overvalued right now?
LENZ Therapeutics (LENZ) has a current Change In Inventory of $-0.89 Mil. The current Change In Inventory is $-0.89 Mil. LENZ Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For LENZ Therapeutics (LENZ), the current Change In Inventory is $-0.89 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LENZ Therapeutics Business Description

Address 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
12GF Score

Get the complete analysis for LENZ

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.29
Price